GENEGUT research presented at ICBTM Conference in Hungary
GENEGUT Coordinator Prof. Caitriona O’Driscoll was invited to deliver a plenary lecture at the ICBTM Conference, held in Debrecen, Hungary, on 25 June 2026.
GENEGUT successfully hosts cluster event on advancing RNA therapeutics for inflammatory bowel disease
On 24 June 2026, the GENEGUT consortium hosted an online cluster event dedicated to advancing RNA therapeutics for inflammatory bowel disease (IBD).
GENEGUT Cluster Event to bring together research, policy and patient perspectives on RNA therapeutics for inflammatory bowel disease
On 24 June 2026, the GENEGUT project will host its Cluster Event: Advancing RNA Therapeutics for Inflammatory Bowel Disease, bringing together representatives of Horizon Europe projects, research organisations, industry, policy and patient communities to discuss the future of RNA-based therapies for inflammatory bowel disease (IBD).
GENEGUT Seminar: Engineering and producing cyclodextrins for medical applications | Dr. Matthew O’Connor
We are pleased to announce the fourth online seminar in the GENEGUT Seminar Series, featuring Dr. Matthew O’Connor, CEO of Scientific Affairs and Director at Cyclarity Therapeutics. The seminar, titled “Engineering and producing cyclodextrins for medical applications”, will take place on 2 July 2026 from 17:00–18:00 CET.
GENEGUT showcased at the European Drug Absorption Network Meeting 2026
The GENEGUT Project Coordinator, Caitriona O’Driscoll, presented the project at the annual meeting of the European Drug Absorption Network (EDAN), held in Sofia, Bulgaria, on 19 May 2026.
World IBD Day 2026: GENEGUT, IFCCA and Crohn’s Colitis Ireland highlight access to IBD care
Today, on World IBD Day 2026, GENEGUT is joining voices with the International Federation of Crohn’s and Ulcerative Colitis Associations (IFCCA) and Crohn’s Colitis Ireland (CCI) to highlight a message that matters deeply to people living with Inflammatory Bowel Disease (IBD): access to IBD care should not depend on where you live.